ABBREVIATIONS
Ψ, pseudouridine; A-to-I, Adenosine-to-Inosine; AML, Acute Myeloid
Leukaemia; AZA, 5-azacytidine; CDS, coding regions; CML, chronic myeloid
leukaemia; CTCL, cutaneous T-cell lymphoma; DNMT, DNA
methyltransferases; ESCC, oesophageal squamous cell carcinoma; EMT,
epithelial-mesenchymal transition; GBM, glioblastoma multiforme; HCC,
hepatocellular carcinoma; HDAC, histone desacetylases; hm5C,
5‑hydroxylmethyl cytidine; HMT, histone methyltransferases; HNSCC, Head
and Neck Squamous Carcinoma KMT, lysine protein methyltransferases; m1A,
N1-methyladenosine; m5C, 5‑methyl cytidine; m6A, N6-methyladenosine; MA,
meclofenamic acid; MA2, ethyl ester form of meclofenamic acid;MDS, myelodysplastic syndrome; MM, multiple myeloma; mRNA, messenger
RNA; miRNA, microRNA ncRNA, non-coding RNA; NSCLC, non-small cell lung
cancer; PDX, patient-derived xenograft; PTCL, peripheral T-cell
lymphoma; rRNA, ribosomal RNA; SAM, S-adenosylmethionine; tRNA, transfer
RNA; UTR, untranslated regions.